跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NBL Multi Elderberry plus A C E Zinc and D3 - TGA Drug Approval Details
Approvals
/
TGA
/
NBL Multi Elderberry plus A C E Zinc and D3
Approved
STANDARD
NBL Multi Elderberry plus A C E Zinc and D3
Aussia Pharma
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
cb62a29e8ab34d91
Company
Aussia Pharma
Type
Standard
Approval Details
Approval Id
cb62a29e8ab34d91
Product Name
NBL Multi Elderberry plus A C E Zinc and D3
Artg Id
372078
Artg Name
NBL Multi Elderberry plus A C E Zinc and D3
Sponsor
Aussia Pharma
Company Detail Path
/organization/aussia-pharma-oem-services-pty-ltd
Artg Date
2021-08-03
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
cb62a29e8ab34d91
Type
Standard
Back to TGA Approvals
